The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV
Open accessAbstract
Background . When the bivalent and the quadrivalent HPV vaccines were marketed they were presented as having comparable efficacy against cervical cancer. Differences between the vaccines are HPV types included and formulation of the adjuvant. Method . A systematic review was conducted to assess the efficacy of the two vaccines against cervical cancer. Outcomes considered were CIN2+, CIN3+, and AIS. Results . Nine reports (38,419 women) were included. At enrolment mean age of women was 20 years, 90% had negative cytology, and 80% were seronegative and/or DNA negative for HPV 16 or 18 (naïve women). In the TVC-naïve, VE against CIN2+ was 58% (95% CI: 35, 72); heterogeneity was detected, VE being 65% (95% CI: 54, 74) for the bivalent and 43% (95% CI: 23, 57) for the quadrivalent. VE against CIN3+ was 78% (95% CI: <0, 97); heterogeneity was substantial, VE being 93% (95% CI: 77, 98) for the bivalent and 43% (95% CI: 12, 63) for the quadrivalent. VE in the TVC was much lower. No sufficient data were available on AIS. Conclusions . In naïve girls bivalent vaccine shows higher efficacy, even if the number of events detected is low. In women already infected the benefit of the vaccination seems negligible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N., Apter, D. L., Kitchener, H. C., Castellsague, X., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60946-5 · Cited by 1,315
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Le, M., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J. M., Bocchini, J. A., & Unger, E. R. (2014) · PubMed · Cited by 924
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Paavonen, J., Iversen, O.-E., Olsson, S.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 806
Worldwide burden of gynaecological cancer: The size of the problem
Sankaranarayanan, R., & Ferlay, J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2005.10.007 · Cited by 731
EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION
KOUTSKY, L. A., GALLOWAY, D. A., & HOLMES, K. K. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036020 · Cited by 711
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., Skinner, S. R., Apter, D., Naud, P., Salmerón, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70286-8 · Cited by 704
Jiles, R. B., Hughes, E., Murphy, W., Flowers, N., McCracken, M., Roberts, H., Ochner, M., Balluz, L. S., Mokdad, A., Elam–Evans, L. D., et al. (2005) · PubMed · Cited by 595
Ault, K. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60852-6 · Cited by 590
Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases
Clifford, G., Franceschi, S., Diaz, M., Muñoz, N., & Villa, L. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.026 · Cited by 568
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Moscicki, A.-B. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 557
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
The known unknowns of HPV natural history
Gravitt, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57149 · Cited by 378
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Serrano, B., Alemany, L., Tous, S., Bruni, L., Clifford, G. M., Weiss, T., Bosch, F. X., & de Sanjosé, S. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-38 · Cited by 301
The Promise of Global Cervical-Cancer Prevention
Schiffman, M., & Castle, P. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058171 · Cited by 286
Lu, B., Kumar, A., Castellsagué, X., & Giuliano, A. R. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-13 · Cited by 283
Fairley, C. K., Hocking, J. S., Gurrin, L. C., Chen, M. Y., Donovan, B., & Bradshaw, C. S. (2009) · Sexually Transmitted Infections · doi:10.1136/sti.2009.037788 · Cited by 223
Joura, E. A., Kjaer, S. K., Wheeler, C. M., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 198
Roteli-Martins, C. M., Naud, P., De Borba, P., Teixeira, J. C., De Carvalho, N. S., Zahaf, T., Sanchez, N., Geeraerts, B., & Descamps, D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18865 · Cited by 192
Rambout, L., Hopkins, L., Hutton, B., & Fergusson, D. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070948 · Cited by 187
De Carvalho, N., Teixeira, J., Roteli-Martins, C. M., Naud, P., De Borba, P., Zahaf, T., Sanchez, N., & Schuind, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.007 · Cited by 169
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Fox, B., Scholar, S., Rosen, J., Chakhtoura, N., Meric, D., Dessy, F. J., et al. (2011) · Human Vaccines · doi:10.4161/hv.7.12.18281 · Cited by 163
Prevalence and risk factors of HPV infection among women from various provinces of the world
Vinodhini, K., Shanmughapriya, S., Das, B. C., & Natarajaseenivasan, K. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2155-8 · Cited by 160
Romanowski, B. (2011) · Human Vaccines · doi:10.4161/hv.7.2.13690 · Cited by 127
Jit, M., Chapman, R., Hughes, O. R., & Choi, Y. H. (2011) · BMJ · doi:10.1136/bmj.d5775 · Cited by 125
on behalf of the ARTISTIC Study Group, Sargent, A., Bailey, A. C., Almonte, M., Turner, A. J., Thomson, C., Peto, J., Desai, M., Mather, J., Moss, S., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604324 · Cited by 121
Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
Schiller, J. T., & Lowy, D. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/599988 · Cited by 119
Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases
Frazer, I. H., Cox, J. T., Mayeaux, E. J., Franco, E. L., Moscicki, A., Palefsky, J. M., Ferris, D. G., Ferenczy, A. S., & Villa, L. L. (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000196485.86376.46 · Cited by 112
Lehtinen, M., Apter, D. L., Dubin, G. O., Kosunen, E., Isaksson, R., Korpivaara, E.-L., Kyhä-Österlund, L., Lunnas, T., Luostarinen, T., Niemi, L., et al. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206778145550 · Cited by 80
Pérez, G., Lazcano-Ponce, E. C., Hernández‐Ávila, M., Garcia, P. J., Muñóz, N., Villa, L. L., Bryan, J. T., Taddeo, F. J., Lu, S., Esser, M. T., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23260 · Cited by 75
Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
Stanley, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603695 · Cited by 72
Oakeshott, P., Aghaizu, A., Reid, F., Howell‐Jones, R., Hay, P., Sadiq, S. T., Lacey, C. J., Beddows, S. A., & Soldan, K. (2012) · BMJ · doi:10.1136/bmj.e4168 · Cited by 70
Clinical trial data for all drugs in current use
Godlee, F. (2012) · BMJ · doi:10.1136/bmj.e7304 · Cited by 57
Tay, E. H., Garland, S. M., Tang, G., Nolan, T. M., Huang, L., Orloski, L., Lu, S., & Barr, E. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.03.021 · Cited by 51
Konno, R., Tamura, S., Dobbelaere, K., & Yoshikawa, H. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181da2128 · Cited by 44
Human papillomavirus: science and technologies for the elimination of cervical cancer
Bosch, F. X. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.596527 · Cited by 43
Efficacy of Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years
Konno, R., Tamura, S., Dobbelaere, K., & Yoshikawa, H. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181d373a5 · Cited by 43
Mattheij, I., Pollock, A. M., & Brhlíková, P. (2012) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2012.110343 · Cited by 40
Barzon, L., Squarzon, L., Masiero, S., Pacenti, M., Marcati, G., Mantelli, B., Gabrielli, L., Pascucci, M. G., Lazzarotto, T., Caputo, A., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.014 · Cited by 39
Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology
Orozco-Colín, A., Carrillo‐García, A., Méndez-Tenorio, A., Ponce‐de‐León, S., Mohar, A., Maldonado‐Rodríguez, R., Guerra-Arias, R., Flores-Gil, O., Sotelo-Regil, R., & Lizano, M. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.07.007 · Cited by 37
Majewski, S. T., Bosch, F. X., Dillner, J., Iversen, O. L. E. E., Kjær, S. K., Muñóz, N., Olsson, S., Paavonen, J. A., Sigurdsson, K., Bryan, J. T., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03266.x · Cited by 35
Polzer, J., & Knabe, S. (2012) · The Journal of Sex Research · doi:10.1080/00224499.2011.644598 · Cited by 35
Barr, E., Gause, C. K., Bautista, O. M., Railkar, R. A., Lupinacci, L. C., Insinga, R. P., Sings, H. L., & Haupt, R. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.001 · Cited by 34
del Amo, J., González, C., Belda, J., Fernández, E., Martínez, R., Gómez, I. C., Torres, M., Saiz, A. G., & Ortiz, M. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1293 · Cited by 26
Rey‐Ares, L. (2012) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2012.483 · Cited by 22
Liu, B. C., Donovan, B. J., Brotherton, J. M. L., Saville, M., & Kaldor, J. M. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051307 · Cited by 11
Cited by
Interaction between the gut microbiome and mucosal immune system
Shi, N., Li, N., Duan, X., & Niu, H. (2017) · Military Medical Research · doi:10.1186/s40779-017-0122-9 · Cited by 940
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Roles and applications of probiotic Lactobacillus strains
Zhang, Z., Lv, J., Pan, L., & Zhang, Y. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9217-9 · Cited by 289
Mekonnen, Y. A., Gültas, M., Effa, K., Hanotte, O., & Schmitt, A. O. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01095 · Cited by 37
Metadata
- Authors
- Di Mario, S., Basevi, V., Lopalco, P. L., Balduzzi, S., D’Amico, R., & Magrini, N.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W1697889365
- Cited by
- 257
- References
- 58
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.